VAXART : Corporate Presentation
MarketScreener,
Forward-Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties.
Coronavirus Vaccine Tracker
New York Times,
Vaccines typically require years of research and testing before reaching the clinic, but in 2020, scientists embarked on a race…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Jotup,
The IND clearance and the initiation of our Phase 1 clinical trial moves us a step closer to proving the superiority of our…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Biz Wire Express,
Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
TMCnet.com,
] Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
VAXART : Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
MarketScreener,
Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Morning Star,
Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
GlobeNewswire,
Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
ForexTV,
Recruitment for Phase 1 clinical study expected to start this month Data from ongoing hamster challenge study expected in…
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Biospace,
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing…
COVID-19 roundup: SpyBiotech-Serum Institute of India send HBV-based COVID-19 vaccine to clinic; plus Vaxart, Inovio-Thermo Fisher and RedHill
BioCentury,
Product Development Sep 9, 2020 | 12:58 AM GMT SpyBiotech, Serum Institute of India start vaccine trial U.K.
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Jotup,
The manuscript describes the pre-clinical development of a SARS-CoV-2 (COVID-19) vaccine based on Vaxarts oral adenovirus…
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Biz Wire Express,
Triggering mucosal immunity may be crucial for effective protection against SARS-CoV-2 infection and transmission Vaxart’s…
Vaxart's Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
TMCnet.com,
] Triggering mucosal immunity may be crucial for effective protection against SARS-CoV-2 infection and transmission Vaxart’s…
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
GlobeNewswire,
Triggering mucosal immunity may be crucial for effective protection against SARS-CoV-2 infection and transmission Vaxart’s oral…
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Biospace,
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology…